Literature DB >> 31121149

Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension.

Inderjit Singh1, Rudolf K F Oliveira2, Robert Naeije3, Farbod N Rahaghi4, William M Oldham4, David M Systrom4, Aaron B Waxman5.   

Abstract

BACKGROUND: Exercise stress testing of the pulmonary circulation may uncover decreased pulmonary vascular (PV) distensibility as a cause of impaired aerobic exercise capacity and right ventricular (RV)-pulmonary arterial (PA) uncoupling. As such, it may help in the differential diagnosis of unexplained dyspnea, including pulmonary hypertension (PH) and/or heart failure with preserved ejection fraction (HFpEF). We investigated rest and exercise invasive pulmonary hemodynamics, ventilation, and gas exchange in patients with unexplained dyspnea, including 44 patients with HFpEF (of whom 20 had a normal pulmonary vascular resistance [PVR] during exercise [ie, passive HFpEF] and 24 had a higher than normal exercise PVR), 22 patients with exercise PH, 19 patients with pulmonary arterial hypertension (PAH), and 24 age- and sex-matched normal control subjects.
METHODS: A PV distensibility coefficient α (%/mm Hg) was determined from multipoint PV pressure-flow plots. RV-PA coupling was quantified from the analysis of RV pressure curves to determine ratios of end-systolic to arterial elastances (Ees/Ea). Aerobic exercise capacity was estimated by peak oxygen consumption.
RESULTS: The α coefficient decreased from 1.35 ± 0.58%/mm Hg in control subjects and 1.1 ± 0.48%/mm Hg in patients with passive HFpEF to 0.62 ± 0.32%/mm Hg in exercise PH, 0.54 ± 0.27%/mm Hg in HFpEF with high exercise PVR, and 0.18 ± 0.16%/mm Hg in PAH. On multivariate analysis, PV distensibility was associated with decreased Ees/Ea and maximal volume of oxygen consumed.
CONCLUSIONS: PV distensibility is an early and sensitive hemodynamic marker of PV disease that is associated with RV-PA uncoupling and decreased aerobic exercise capacity.
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RV-PA coupling; exercise capacity; heart failure; pulmonary arterial hypertension; pulmonary vascular distensibility

Year:  2019        PMID: 31121149     DOI: 10.1016/j.chest.2019.04.111

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Association of obesity-related inflammatory pathways with lung function and exercise capacity.

Authors:  Jenna N McNeill; Emily S Lau; Emily K Zern; Matthew Nayor; Rajeev Malhotra; Elizabeth E Liu; Rohan R Bhat; Liana C Brooks; Robyn Farrell; John A Sbarbaro; Mark W Schoenike; Benjamin D Medoff; Gregory D Lewis; Jennifer E Ho
Journal:  Respir Med       Date:  2021-04-30       Impact factor: 4.582

Review 2.  The physiological basis of pulmonary arterial hypertension.

Authors:  Robert Naeije; Manuel J Richter; Lewis J Rubin
Journal:  Eur Respir J       Date:  2022-06-16       Impact factor: 33.795

3.  Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction.

Authors:  Hannah T Oakland; Phillip Joseph; Ahmed Elassal; Marjorie Cullinan; Paul M Heerdt; Inderjit Singh
Journal:  Pulm Circ       Date:  2020-11-25       Impact factor: 3.017

4.  Expression of the microRNA-30 family in pulmonary arterial hypertension and the role of microRNA-30d-5p in the regulation of pulmonary arterial smooth muscle cell toxicity and apoptosis.

Authors:  Fan Hu; Hanmin Liu; Chuan Wang; Hanwen Li; Lina Qiao
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

5.  Pressure-based estimation of right ventricular ejection fraction.

Authors:  Paul M Heerdt; Inderjit Singh; Ahmed Elassal; Vitaly Kheyfets; Manuel J Richter; Khodr Tello
Journal:  ESC Heart Fail       Date:  2022-02-12

6.  The Paradox of Pulmonary Vascular Resistance: Restoration of Pulmonary Capillary Recruitment as a Sine Qua Non for True Therapeutic Success in Pulmonary Arterial Hypertension.

Authors:  David Langleben; Stylianos E Orfanos; Benjamin D Fox; Nathan Messas; Michele Giovinazzo; John D Catravas
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

Review 7.  Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology.

Authors:  Michael H Lee; Thaís C F Menezes; Julie A Reisz; Eloara V M Ferreira; Brian B Graham; Rudolf K F Oliveira
Journal:  Front Physiol       Date:  2022-09-12       Impact factor: 4.755

8.  Arterial load and right ventricular-vascular coupling in pulmonary hypertension.

Authors:  Hannah Oakland; Phillip Joseph; Robert Naeije; Ahmed Elassal; Marjorie Cullinan; Paul M Heerdt; Inderjit Singh
Journal:  J Appl Physiol (1985)       Date:  2021-05-27

Review 9.  Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?

Authors:  Barbro Kjellström; Anthony Lindholm; Ellen Ostenfeld
Journal:  Curr Heart Fail Rep       Date:  2020-10

Review 10.  Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension.

Authors:  Jorge Reyes-García; Abril Carbajal-García; Annarita Di Mise; Yun-Min Zheng; Xiangdong Wang; Yong-Xiao Wang
Journal:  Antioxidants (Basel)       Date:  2022-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.